Biosafety Protocols for Diagnostic Specimen Transport: Ensuring Safety and Compliance

Diagnostic specimen transport connects sample collection sites to testing laboratories, and failures in this chain compromise patient care and create biosafety risks. This article defines the core elements of a biosafety protocol for specimen transport, including packaging, labeling, documentation, and quality control, with practical steps for laboratory students, technicians, researchers, and diagnostic professionals. The content focuses on decisions you make before shipment, during transport, and at receipt, with emphasis on compliance and safety.

Scope and Context for Specimen Transport Biosafety

Clinical laboratories rarely know whether patient specimens contain infectious agents, which makes biosafety during testing and transport challenging. Patient care and public health require timely, reliable laboratory testing, yet the infectious status of specimens is often unknown at the point of collection. This uncertainty means every specimen must be handled according to a defined biosafety protocol instead of assumptions about risk. The 2014 Ebola outbreak demonstrated that biosafety concerns can delay diagnoses and contribute to patient deaths when laboratories lack clear procedures for handling potentially infectious materials. Clinical laboratory professionals face the ongoing challenge of ensuring biosafety while performing testing procedures on specimens of unknown infectious status. These findings come from a collaborative review of clinical laboratory biosafety gaps published in Clinical Microbiology Reviews.

The complexity of clinical laboratories adds another layer to transport biosafety. Current biosafety guidance largely derives from research laboratory practices, which do not always correspond to the unique clinical laboratory environment with its specialized equipment and processes. Risk assessment and management, specimen collection, processing, storage, equipment safety, disinfection practices, personal protective equipment, waste management, and personnel training all factor into a complete transport protocol. A retrospective analysis of biosafety gaps identified opportunities for improvement across these areas, including specimen collection and processing, test utilization, and laboratory personnel training and competency assessment, as documented in the same Clinical Microbiology Reviews analysis.

For diagnostic professionals, the practical implication is that transport protocols must be written for your specific setting. A protocol that works for a centralized reference laboratory may not fit a district hospital or a field collection site. The specimen referral system in Ghana illustrates this point. A landscape assessment found that health management teams at regional and district levels had packaging guidelines or standard operating procedures for biological specimens in 66 percent of cases, but only 28 percent of referring facilities had these guidelines. Only 45 percent of referring facilities had at least one health worker trained in specimen packaging. This gap between central guidance and frontline practice is a common failure pattern in specimen transport systems, as reported in the Ghana specimen referral system assessment.

At a Glance

The table below summarizes the key decisions and requirements for each stage of the specimen transport workflow.

Core Principles of Safe Specimen Transport

The Triple Packaging System

The triple packaging system is the foundational standard for transporting diagnostic specimens. This system uses three layers of containment to prevent leakage and protect handlers. The primary container holds the specimen and must be leak-proof and watertight. The secondary container surrounds the primary container and must also be leak-proof. The outer packaging protects the inner layers during transport and carries the labeling and documentation.

For infectious substances, the primary container should be sealed with a closure that prevents leakage during transport. Absorbent material must be placed between the primary and secondary containers to absorb any liquid that might escape if the primary container breaks. The secondary container should be durable enough to withstand pressure changes and temperature variations encountered during transport. The outer packaging must be rigid enough to protect the contents from physical damage and must meet applicable transport regulations for the mode of shipment.

The triple packaging system applies to all diagnostic specimens, also those known to contain high-risk pathogens. Because the infectious status of specimens is often unknown, consistent use of triple packaging reduces the risk of exposure for transport personnel, couriers, and laboratory staff who receive the packages. The World Health Organization Laboratory Biosafety Manual provides guidance on packaging requirements and biosafety practices for transporting infectious materials.

Risk Assessment Before Transport

A strict biosafety risk assessment should be conducted on biological specimens based on virus load information, infectivity, and sample type. Possible transmission routes include contact transmission, aerosol transmission, and fecal oral transmission. This assessment guides decisions about packaging, transport conditions, and the level of personal protective equipment required for handlers. Guidance from the Journal of Zhejiang University Medical Sciences emphasizes that risk assessment must consider these factors before specimen collection, transport, handling, preservation, and detection.

For specimens from patients with known or suspected high-consequence pathogens, the risk assessment may require additional precautions beyond standard triple packaging. For example, specimens collected during outbreaks of viral hemorrhagic fevers or novel respiratory viruses may need dedicated transport arrangements, trained couriers, and specific decontamination procedures. The risk assessment should be documented and reviewed whenever the clinical context changes. The World Health Organization Laboratory Quality Management System Handbook addresses quality management aspects of laboratory operations, including specimen transport and risk management.

The risk assessment also informs decisions about transport medium. Some transport media inactivate pathogens while preserving nucleic acids for molecular testing. A study of a cold chain independent specimen collection and transport medium found that it inactivated SARS-CoV-2 in less than 15 minutes and allowed transport at temperatures from 15 to 40 degrees Celsius. This medium improved diagnostic sensitivity compared to commercial viral transport medium in field studies, as reported in Microbiology Spectrum. For laboratories in settings where cold chain transport is unreliable, inactivation media can reduce biosafety risks while preserving specimen quality.

Temperature Control and Specimen Integrity

Specimen integrity depends on maintaining appropriate temperatures during transport. Many diagnostic specimens require cold chain transport to preserve nucleic acids, proteins, or viable organisms. The requirement for cold chain transport creates both logistical and biosafety challenges, particularly in low resource settings where infrastructure constraints limit access to molecular diagnostics. The Microbiology Spectrum study documented that in India, approximately 65 percent of the population lives in villages where infrastructural constraints limit access to molecular diagnostics, and the requirement for cold chain transport poses major bottlenecks to equitable access.

When cold chain transport is not available, alternative approaches may be necessary. Transport media that stabilize specimens at ambient temperatures can reduce the need for cold chain logistics. These media must be validated for the specific tests being performed. The same Microbiology Spectrum study demonstrated that a transport medium allowing cold chain independent transport at temperatures from 15 to 40 degrees Celsius improved diagnostic sensitivity for COVID-19 molecular diagnosis compared to commercial viral transport medium. The medium captured more symptomatic and asymptomatic cases and yielded lower quantitative PCR threshold cycle values.

Temperature monitoring during transport should be documented. Temperature indicators or data loggers can verify that specimens remained within acceptable ranges. If temperature excursions occur, the receiving laboratory must decide whether to reject the specimens or proceed with testing while noting the potential impact on results. This decision should follow a written policy that considers the test type, the duration and magnitude of the temperature excursion, and the clinical significance of potential degradation.

Packaging Standards and Materials

Primary Container Selection

The primary container must be appropriate for the specimen type and the transport conditions. Leak-proof tubes with secure closures are standard for liquid specimens such as blood, urine, and cerebrospinal fluid. Swabs should be placed in tubes containing transport medium to maintain viability of organisms and prevent drying. For specimens that generate aerosols during collection, such as respiratory samples, the primary container should be opened only in a biosafety cabinet. The Enfermedades infecciosas y microbiologia clinica review emphasizes that the type of specimen, the appropriate time to obtain the sample, the way of sampling, the storage and transport are critical points in the diagnostic process.

Container quality matters. Poor quality tubes can crack or leak during transport, exposing handlers to infectious materials. Use containers from reputable manufacturers and inspect them for defects before use. The container must be compatible with the transport medium and must not react with the specimen in ways that affect test results.

For cryopreserved specimens, the risks of cross contamination are specific. Cross contamination between liquid nitrogen and embryos can occur when infectious agents are present in liquid nitrogen and embryos are not protected by a sealed container. Direct contact of germplasm and reproductive tissues with liquid nitrogen during cryopreservation and storage should be prevented as a mandatory measure for reducing contamination risk. Hermetically sealed, shatter proof freezing containers or secondary enclosures such as double bagging or straw in straw systems reduce this risk. Periodic disinfection of cryo Dewars is an additional precaution, and separate Dewars should be used to quarantine specimens from infected donors or unknown health status, as documented in Advances in Experimental Medicine and Biology.

Absorbent Material and Cushioning

Absorbent material must be placed between the primary and secondary containers. The amount of absorbent material should be sufficient to absorb the entire contents of the primary container in case of leakage. For a 5 milliliter blood tube, the absorbent material should be able to absorb at least 5 milliliters of liquid. Common absorbent materials include cellulose wadding, absorbent pads, and superabsorbent polymers.

Cushioning material protects the primary container from physical shock during transport. The secondary container should be packed tightly enough to prevent movement of the primary container but not so tightly that the primary container is compressed or damaged. Foam inserts, bubble wrap, and corrugated cardboard dividers are common cushioning materials.

Outer Packaging Requirements

The outer packaging must be rigid and durable enough to withstand the rigors of transport. It must bear the appropriate labels and markings for the contents. The outer packaging should be large enough to accommodate the secondary container with absorbent material but not so large that the contents shift during transport.

For shipments of infectious substances, the outer packaging must meet applicable transport regulations. These regulations vary by country and by mode of transport. Air transport regulations are typically the most stringent. The outer packaging must be tested and certified for the transport of infectious substances if the contents meet the definition of a dangerous good.

Labeling and Documentation

Required Label Elements

Labels on the outer packaging must clearly identify the contents and the hazards. At minimum, the label should include the words "Diagnostic Specimen" or the appropriate hazard classification for the contents. The label should include the name, address, and telephone number of the shipper and the receiver. For infectious substances, the label must include the United Nations number and proper shipping name for the substance.

The label should be affixed to the outside of the outer packaging and must be legible and durable. Labels that can be damaged by moisture, abrasion, or temperature extremes should be protected with clear tape or placed in label holders. The label must not obscure other required markings on the packaging.

Documentation for Shipment

Documentation accompanying the shipment should include a packing list or manifest that identifies the contents, the number of packages, and the destination. For infectious substances, a shipper's declaration may be required. This declaration certifies that the contents are properly classified, packaged, marked, and labeled.

The documentation should include contact information for the shipper and the receiver, including telephone numbers for emergency contact. For shipments crossing international borders, additional documentation may be required, including import permits, export permits, and health certificates. The shipper is responsible for ensuring that all required documentation is complete and accurate.

Chain of Custody Records

Chain of custody records document the movement of specimens from collection to testing. These records should include the date and time of collection, the date and time of shipment, the transport method, the courier or transport service, and the date and time of receipt at the laboratory. Each transfer of custody should be documented with signatures or electronic records.

Chain of custody records serve multiple purposes. They provide a record of specimen integrity for quality assurance. They support investigations if specimens are lost, damaged, or delayed. They also provide evidence of compliance with transport regulations and institutional policies.

Transport Workflow and Logistics

Preparing Shipments for Transport

The preparation of shipments for transport should follow a written standard operating procedure. This procedure should specify the steps for selecting the primary container, adding absorbent material, placing the primary container in the secondary container, sealing the secondary container, placing the secondary container in the outer packaging, and applying labels and documentation.

Each step should be verified before proceeding to the next step. A checklist can help ensure that no steps are missed. The checklist should include verification that the primary container is leak-proof, that absorbent material is sufficient for the specimen volume, that the secondary container is properly sealed, and that the outer packaging is labeled correctly.

Selecting Transport Methods

The transport method must balance speed, cost, and safety. A pilot study in Mali compared the use of trained postal services to public transportation for shipping specimens from district to central level. Only 46 percent of samples sent by public transportation were received within 72 hours of collection, compared to 71 percent of samples shipped via the postal service. Further, 93 percent of samples shipped by public transportation arrived in good condition, compared to 98 percent by postal service. The average cost per specimen was 8 times higher with the postal service, as reported in Health Security.

This study illustrates the tradeoffs in transport method selection. Public transportation may be cheaper but slower and less reliable. Trained courier services may be faster and safer but more expensive. The decision should consider the clinical urgency of the tests, the stability of the specimens, and the available budget.

For routine specimens, a scheduled courier service with trained personnel is often the best option. For urgent specimens, dedicated transport may be necessary. For specimens that require cold chain, the transport method must be able to maintain the required temperature range.

Receiving and Opening Packages

The receiving laboratory must have procedures for inspecting incoming packages and opening them safely. The receiving area should be clean and well lit, with access to personal protective equipment and decontamination supplies. Packages should be inspected for signs of damage or leakage before opening.

If a package is damaged or leaking, the receiving personnel should not open it. The package should be isolated and the shipper and appropriate authorities should be notified. Decontamination procedures should be available for cleaning up spills.

When opening packages, the receiving personnel should wear appropriate personal protective equipment, including gloves and a laboratory coat. The outer packaging should be opened first, followed by the secondary container. The primary container should be inspected for damage before it is opened. If the primary container is damaged, the specimen should be handled as a potential exposure.

Quality Control and Assurance

Validation of Transport Conditions

Transport conditions should be validated before a new transport method or route is implemented. Validation should include testing the packaging system with simulated shipments, monitoring temperatures during transport, and verifying that specimen quality is maintained. The validation should be documented and reviewed periodically.

For temperature sensitive specimens, validation should include temperature monitoring under worst case conditions, such as summer heat or winter cold. Temperature data loggers can record temperatures throughout the transport route. The data should be reviewed to confirm that temperatures remained within acceptable ranges.

Monitoring and Metrics

Transport performance should be monitored using defined metrics. Common metrics include on time delivery rates, specimen rejection rates, and the percentage of specimens arriving in good condition. A case study of microbiology laboratory consolidation in Dubai Health reported a 98.57 percent on time delivery rate for routine samples and 97.90 percent for critical samples. Specimen rejection rates decreased from 0.50 percent to 0.05 percent after consolidation, as documented in the International Journal of Infectious Diseases Regional Reports.

These metrics provide a baseline for evaluating transport performance. When metrics fall below targets, the transport system should be investigated to identify the cause. Common causes of poor performance include inadequate training, unreliable transport services, and packaging failures.

Training and Competency Assessment

Personnel involved in specimen transport must be trained in packaging, labeling, documentation, and safety procedures. Training should be documented and refreshed periodically. Competency should be assessed through observation, written tests, or both.

The Ghana landscape assessment found that only 45 percent of referring facilities had at least one health worker trained in specimen packaging, as reported in the Ghana specimen referral system assessment. This gap in training is a common failure pattern. Training programs should be practical and should include hands on practice with packaging and labeling. Training should also cover what to do in case of spills, leaks, or other emergencies.

Common Failure Patterns in Specimen Transport

Packaging Failures

Packaging failures are among the most common problems in specimen transport. Leaking primary containers, insufficient absorbent material, and inadequate outer packaging can all lead to exposure of handlers and contamination of the transport environment. Packaging failures are often caused by using poor quality containers, overfilling primary containers, or failing to secure closures properly.

Prevention of packaging failures starts with using quality containers and following the triple packaging system consistently. Each package should be inspected before shipment to verify that all components are in place and properly assembled. A checklist can help ensure that no steps are missed.

Temperature Excursions

Temperature excursions occur when specimens are exposed to temperatures outside the acceptable range during transport. These excursions can degrade specimen quality and lead to false negative or inaccurate test results. Temperature excursions are more common in settings where cold chain transport is unreliable or where transport times are long.

Prevention of temperature excursions requires appropriate packaging for temperature control, such as insulated containers with cold packs, and monitoring of temperatures during transport. When temperature excursions are detected, the receiving laboratory should be notified and the impact on test results should be assessed.

Documentation Errors

Documentation errors include missing or incorrect labels, incomplete chain of custody records, and missing permits or declarations. These errors can delay testing, cause specimens to be rejected, and create compliance problems. Documentation errors are often caused by inadequate training or by rushing through the preparation process.

Prevention of documentation errors requires clear procedures and checklists. The person preparing the shipment should verify that all labels and documentation are complete and accurate before the shipment leaves the facility. A second person can review the documentation as a quality check.

Delays in Transport

Delays in transport can compromise specimen quality and delay clinical decisions. Delays are more common when transport relies on public transportation or when courier services are unreliable. The Mali pilot study found that only 46 percent of samples sent by public transportation were received within 72 hours of collection, compared to 71 percent shipped via the postal service, as reported in Health Security.

Prevention of delays requires selecting reliable transport methods and monitoring performance. When delays occur, the receiving laboratory should be notified and the impact on specimen quality should be assessed. For urgent specimens, alternative transport arrangements may be necessary.

Biosafety Considerations for Specific Specimen Types

Respiratory Specimens

Respiratory specimens, including nasopharyngeal swabs, throat swabs, and sputum, may contain respiratory pathogens that are transmitted by aerosols. Collection of these specimens can generate aerosols, and handling of the specimens after collection can also generate aerosols. The primary container should be opened only in a biosafety cabinet.

Transport of respiratory specimens should follow the triple packaging system. The transport medium should be appropriate for the suspected pathogen. Some transport media inactivate pathogens while preserving nucleic acids, which can reduce biosafety risks during transport and processing. A study in the Journal of Clinical Microbiology evaluated 23 commercial reagents designed for clinical sample transportation, nucleic acid extraction, and virus inactivation for their ability to inactivate SARS-CoV-2, along with seven other common chemicals including detergents and fixatives. This study provides a framework for laboratories to validate their inactivation processes and to guide similar studies for other pathogens.

Blood and Body Fluid Specimens

Blood and body fluid specimens may contain bloodborne pathogens, including hepatitis viruses and human immunodeficiency virus. These specimens should be handled with universal precautions, meaning that all blood and body fluids are treated as potentially infectious.

The primary container for blood specimens should be a leak proof tube with a secure closure. The tube should not be overfilled, and the closure should be verified before shipment. Absorbent material should be sufficient to absorb the entire contents of the tube.

Cryopreserved Specimens

Cryopreserved specimens, including embryos, semen, and other reproductive tissues, present specific biosafety challenges. Cross contamination between liquid nitrogen and specimens can occur when infectious agents are present in liquid nitrogen and specimens are not protected by a sealed container. Direct contact of germplasm and reproductive tissues with liquid nitrogen during cryopreservation and storage should be prevented, as documented in Advances in Experimental Medicine and Biology.

For transport of cryopreserved specimens, dry shippers that do not contain liquid nitrogen in a free form can be used. The specimens should be in hermetically sealed, shatter proof containers. A secondary enclosure, such as double bagging or straw in straw, provides additional protection. Periodic disinfection of cryo Dewars is recommended, and separate Dewars should be used to quarantine specimens from infected donors or unknown health status.

Regulatory and Compliance Context

International Transport Regulations

Transport of diagnostic specimens is regulated by international agreements and national laws. The regulations classify specimens as infectious substances or diagnostic specimens based on the known or suspected presence of pathogens. The classification determines the packaging, labeling, and documentation requirements.

Air transport regulations are typically the most stringent. The International Air Transport Association publishes regulations for the transport of dangerous goods by air, including infectious substances. These regulations specify the packaging standards, labeling requirements, and documentation needed for air transport.

National and Institutional Requirements

National regulations may add requirements beyond international standards. For example, some countries require permits for the import or export of diagnostic specimens. Others require that transport personnel be trained and certified. Institutional policies may also add requirements, such as using specific courier services or maintaining chain of custody records.

Laboratory professionals should be familiar with the regulations that apply to their setting. The responsible person for specimen transport should maintain current knowledge of regulatory requirements and should update procedures when regulations change.

Biosafety Guidelines and Standards

The World Health Organization Laboratory Biosafety Manual provides guidance on biosafety practices and procedures for laboratories, covering risk assessment, personal protective equipment, decontamination, and waste management. The World Health Organization Laboratory Quality Management System Handbook addresses the quality management aspects of laboratory operations, including specimen transport. These documents are useful references for developing and updating specimen transport protocols.

For emerging pathogens, biosafety requirements may be stringent and specialized diagnostic capacities may be limited. A review of Nipah virus preparedness noted that in non-endemic regions, preparedness presents distinct challenges due to the rarity of cases, stringent biosafety requirements, and reliance on specialised diagnostic and clinical capacities that may degrade without routine use, as reported in One Health. Specimen handling and biosafety requirements are part of the diagnostic pathway that must be maintained for outbreak readiness.

Practical Implementation Steps

Step 1: Conduct a Risk Assessment

Begin by conducting a risk assessment of your specimen transport system. Identify the types of specimens you transport, the suspected pathogens, the transport routes, and the personnel involved. Consider the potential for exposure at each step of the transport process. The Journal of Zhejiang University Medical Sciences guidance emphasizes that risk assessment should be based on virus load information, infectivity, and sample type, considering possible contact transmission, aerosol transmission, and fecal oral transmission.

Document the risk assessment and review it periodically. The risk assessment should be updated when new pathogens emerge, when transport routes change, or when new evidence about transmission risks becomes available.

Step 2: Write Standard Operating Procedures

Write standard operating procedures for specimen transport that cover packaging, labeling, documentation, and safety. The procedures should be specific to your setting and should include step by step instructions. Include checklists that personnel can use to verify that each step is completed.

The procedures should be reviewed and approved by the responsible person. They should be updated when regulations change, when new equipment is introduced, or when problems are identified.

Step 3: Train Personnel

Train all personnel involved in specimen transport, including collectors, couriers, and receiving laboratory staff. Training should cover the standard operating procedures, the triple packaging system, labeling and documentation requirements, and emergency procedures.

Document the training and assess competency. Refresher training should be provided periodically and when procedures change.

Step 4: Implement Monitoring and Quality Control

Implement monitoring of transport performance using defined metrics. Track on time delivery rates, specimen rejection rates, and the percentage of specimens arriving in good condition. Review the metrics regularly and investigate when performance falls below targets.

Implement quality control checks, such as inspecting packages before shipment and verifying documentation. Use checklists to ensure consistency.

Step 5: Review and Improve

Review the transport system periodically and make improvements based on the data and feedback. Investigate failures to identify root causes and implement corrective actions. Share lessons learned with all personnel involved in specimen transport.

Records and Measurements

Records to Maintain

Maintain records of all specimen shipments, including the date and time of collection, the date and time of shipment, the transport method, the courier or transport service, and the date and time of receipt. Maintain chain of custody records that document each transfer of custody.

Maintain training records for all personnel involved in specimen transport. Maintain records of quality control checks, including package inspections and temperature monitoring. Maintain records of any incidents, including spills, leaks, delays, and temperature excursions.

Measurements to Track

The table below summarizes the key measurements for evaluating transport performance.

These measurements provide a baseline for evaluating performance and identifying areas for improvement.

Professional Escalation Criteria

When to Escalate

Escalate to a supervisor or the responsible person when you encounter any of the following situations:

• A package is damaged or leaking during transport
• A specimen is lost or delayed beyond the expected time frame
• A temperature excursion occurs that may compromise specimen quality
• A documentation error is identified that may affect compliance
• A transport worker is exposed to a specimen
• A spill occurs during transport or receipt

What to Report

When escalating, report the following information:

• The date and time of the incident
• The location of the incident
• The specimens involved
• The transport method and route
• The actions taken to address the incident
• The names of personnel involved

The responsible person should investigate the incident, document the findings, and implement corrective actions to prevent recurrence.

Frequently Asked Questions

What is the triple packaging system for diagnostic specimens?

The triple packaging system uses three layers of containment for transporting diagnostic specimens. The primary container holds the specimen and must be leak proof and watertight. The secondary container surrounds the primary container and must also be leak proof. Absorbent material is placed between the primary and secondary containers to absorb any liquid that might escape. The outer packaging protects the inner layers during transport and carries the labeling and documentation.

How do I choose the right transport medium for my specimens?

The transport medium must preserve the specimen for the tests being performed. For molecular tests, the medium should preserve nucleic acids. For culture, the medium should maintain organism viability. Some transport media inactivate pathogens while preserving nucleic acids, which can reduce biosafety risks. The medium should be validated for the specific tests being performed and for the expected transport conditions, including temperature and time. Studies have shown that inactivation media can improve diagnostic sensitivity while reducing biosafety challenges, as reported in Microbiology Spectrum.

What should I do if a package arrives damaged or leaking?

Do not open a damaged or leaking package. Isolate the package and notify the shipper and appropriate authorities. Use decontamination procedures to clean up any spills. The receiving personnel should wear appropriate personal protective equipment when handling a damaged package.

How do I maintain the cold chain during specimen transport?

Use insulated containers with cold packs or other temperature control materials. Verify that the cold packs are frozen before use and that the container is properly sealed. Monitor temperatures during transport using temperature indicators or data loggers. If a temperature excursion occurs, notify the receiving laboratory and assess the impact on specimen quality.

What documentation is required for shipping diagnostic specimens?

Documentation should include a packing list or manifest that identifies the contents, the number of packages, and the destination. For infectious substances, a shipper's declaration may be required. Chain of custody records should document the movement of specimens from collection to testing. For international shipments, additional documentation may be required, including import permits, export permits, and health certificates.

How often should transport personnel be trained?

Transport personnel should be trained before they begin handling specimens and should receive refresher training periodically. Training should be provided when procedures change, when new equipment is introduced, or when problems are identified. Competency should be assessed through observation, written tests, or both.

What are the most common causes of specimen rejection during transport?

Common causes of specimen rejection include leakage or damage to the primary container, insufficient specimen volume, improper labeling, and temperature excursions that compromise specimen quality. Documentation errors can also cause specimens to be rejected. Prevention requires consistent use of the triple packaging system, proper labeling and documentation, and temperature monitoring during transport.

How do I handle specimens from patients with suspected high consequence pathogens?

Conduct a risk assessment based on the suspected pathogen, the specimen type, and the potential transmission routes. Use the triple packaging system and consider additional precautions, such as dedicated transport arrangements, trained couriers, and specific decontamination procedures. Follow applicable regulations and institutional policies for transporting infectious substances. The World Health Organization Laboratory Biosafety Manual provides guidance on risk assessment and biosafety practices for high consequence pathogens.

Related Diagnostic Guides

• Calibration Process: Steps, Documentation, and Frequency for Lab Equipment
• Pre-Run Laboratory Checklist: Reagents, Instruments, Controls, and Documentation
• Digital Droplet PCR for Absolute Quantification of Feline Enteric Coronavirus RNA in Fecal Samples: Diagnostic Utility and Prognostic Implications
• Protein Immunoprecipitation: Principles and Protocol
• Bacteriology and Diagnostic Staining Techniques

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.. Clinical microbiology reviews, 2021.
• A Cold Chain-Independent Specimen Collection and Transport Medium Improves Diagnostic Sensitivity and Minimizes Biosafety Challenges of COVID-19 Molecular Diagnosis.. Microbiology spectrum, 2021.
• Biosafety in embryos and semen cryopreservation, storage, management and transport.. Advances in experimental medicine and biology, 2014.
• Monkeypox virus diagnosis and laboratory testing.. Reviews in medical virology, 2023.
• [Principles and suggestions on biosafety protection of biological specimen preservation during prevalence of COVID-19].. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2020.
• Sample Transport Optimization: Mali Pilot Study.. Health security, 2020.
• Collection, transport and general processing of clinical specimens in Microbiology laboratory.. Enfermedades infecciosas y microbiologia clinica (English ed.), 2019.
• Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives.. Journal of clinical microbiology, 2020.
• Nipah virus preparedness in a One Health framework: Implications for Europe.. 2026.
• Sustainability Practices and Green Lab Initiatives in Clinical Laboratories in Pakistan: A National e-Survey-Based Analysis.. 2026.
• Improving the specimen referral system in Ghana: findings from a landscape assessment.. 2025.
• Biobanking of vector-borne viruses in the Philippines: basic principles, best practices, and challenges.. 2026.
• Pseudovirus as an Emerging Reference Material in Molecular Diagnostics: Advancement and Perspective.. 2025.
• Microbiology laboratory consolidation: Optimizing diagnostic efficiency and service quality-A case study from Dubai Health, United Arab Emirates.. 2025.
• Principles and suggestions on biosafety protection of biological specimen preservation during prevalence of COVID-19. Zhejiang Da Xue Xue Bao Yi Xue Ban Journal of Zhejiang University Medical Sciences, 2020.
• Expert consensus on biosafety for 2019 novel coronavirus pneumonia in clinical laboratory. Chinese Journal of Laboratory Medicine, 2020.
• Biological Safety in the Storage and Transport of Biological Specimens From Patients With Respiratory Diseases Used in Research Settings. Archivos De Bronconeumologia, 2009.
• Increasing the biosafety of analytical systems in the clinical laboratory. Clinica Chimica Acta, 1994.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.